
What smart money is saying about Rohto Pharmaceutical
1 fund in our archive has pitched Rohto Pharmaceutical — most recently Harding Loevner International Small Companies Equity in June 2025.
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
Fund activity · 2 positions
- HoldsAVI Japanese Special SituationsMay 2026
Listed in AVI Japanese Special Situations’s reported holdings.
Read the letterRohto Pharmaceutical - HoldsInternational Small Companies EquityMay 2026
Listed in International Small Companies Equity’s reported holdings.
Read the letterRohto Pharmaceutical
Fund coverage · 1 thesis
- Harding Loevner International Small Companies EquityJune 2025
Rohto Pharmaceutical is a leader in health and beauty with a smart factory utilizing AI for innovative ophthalmology and regenerative medicine solutions.
Read the full thesis
Read every full thesis on Rohto Pharmaceutical
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→